{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T09:39:22Z","timestamp":1795081162608,"version":"4.10.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41431-025-02006-5","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:22:25Z","timestamp":1767860545000},"page":"421-428","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Insights from 2057 germline genetic tests in renal cell carcinoma patients support revisiting testing criteria"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5202-0212","authenticated-orcid":false,"given":"Roseline","family":"Vibert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"El Baroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maude","family":"Vecten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Verkarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4816-670X","authenticated-orcid":false,"given":"Anne-Paule","family":"Gimenez-Roqueplo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9859-9773","authenticated-orcid":false,"given":"St\u00e9phane","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8190-5853","authenticated-orcid":false,"given":"Judith","family":"Favier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Barlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7972-5845","authenticated-orcid":false,"given":"Nelly","family":"Burnichon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"2006_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","volume":"82","author":"L Bukavina","year":"2022","unstructured":"Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, et al. Epidemiology of renal cell carcinoma: 2022 update. Eur Urol. 2022;82:529\u201342.","journal-title":"Eur Urol"},{"key":"2006_CR2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","volume":"82","author":"H Moch","year":"2022","unstructured":"Moch H, Amin MB, Berney DM, Comp\u00e9rat EM, Gill AJ, Hartmann A, et al. The 2022 World Health Organization classification of tumours of the urinary system and male genital organs, part A: renal, penile, and testicular tumours. Eur Urol. 2022;82:458\u201368.","journal-title":"Eur Urol"},{"key":"2006_CR3","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.eururo.2019.06.015","volume":"76","author":"MI Carlo","year":"2019","unstructured":"Carlo MI, Hakimi AA, Stewart GD, Bratslavsky G, Brugarolas J, Chen YB, et al. Familial kidney cancer: implications of new syndromes and molecular insights. Eur Urol. 2019;76:754\u201364.","journal-title":"Eur Urol"},{"key":"2006_CR4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/ejhg.2010.175","volume":"19","author":"ER Maher","year":"2011","unstructured":"Maher ER, Neumann HP, Richard S. von Hippel\u2013Lindau disease: a clinical and scientific review. Eur J Hum Genet. 2011;19:617\u201323.","journal-title":"Eur J Hum Genet"},{"key":"2006_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1136\/thorax-2024-221738","volume":"80","author":"B Yngvadottir","year":"2025","unstructured":"Yngvadottir B, Richman L, Andreou A, Woodley J, Luharia A, Lim D, et al. Inherited predisposition to pneumothorax: estimating the frequency of Birt-Hogg-Dub\u00e9 syndrome from genomics and population cohorts. Thorax. 2025;80:553\u20135.","journal-title":"Thorax"},{"key":"2006_CR6","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1002\/cncr.32914","volume":"126","author":"B Shuch","year":"2020","unstructured":"Shuch B, Li S, Risch H, Bindra RS, McGillivray PD, Gerstein M. Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer. Cancer. 2020;126:3657\u201366.","journal-title":"Cancer"},{"key":"2006_CR7","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1097\/PAS.0000000000000292","volume":"38","author":"AJ Gill","year":"2014","unstructured":"Gill AJ, Hes O, Papathomas T, \u0160edivcov\u00e1 M, Tan PH, Agaimy A, et al. Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients. Am J Surg Pathol. 2014;38:1588\u2013602.","journal-title":"Am J Surg Pathol"},{"key":"2006_CR8","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/jnci\/djy171","volume":"110","author":"S Walpole","year":"2018","unstructured":"Walpole S, Pritchard AL, Cebulla CM, Pilarski R, Stautberg M, Davidorf FH, et al. Comprehensive study of the clinical phenotype of germline bap1 variant-carrying families worldwide. J Natl Cancer Inst. 2018;110:1328\u201341.","journal-title":"J Natl Cancer Inst"},{"key":"2006_CR9","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s00345-018-2288-5","volume":"36","author":"ER Maher","year":"2018","unstructured":"Maher ER. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management. World J Urol. 2018;36:1891\u20138.","journal-title":"World J Urol"},{"key":"2006_CR10","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1002\/cncr.30893","volume":"123","author":"KA Nguyen","year":"2017","unstructured":"Nguyen KA, Syed JS, Espenschied CR, LaDuca H, Bhagat AM, Suarez-Sarmiento A, et al. Advances in the diagnosis of hereditary kidney cancer: initial results of a multigene panel test. Cancer. 2017;123:4363\u201371.","journal-title":"Cancer"},{"key":"2006_CR11","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/cncr.31908","volume":"125","author":"J Wu","year":"2019","unstructured":"Wu J, Wang H, Ricketts CJ, Yang Y, Merino MJ, Zhang H, et al. Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease. Cancer. 2019;125:1060\u20139.","journal-title":"Cancer"},{"key":"2006_CR12","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.euo.2021.09.005","volume":"4","author":"H Truong","year":"2021","unstructured":"Truong H, Sheikh R, Kotecha R, Kemel Y, Reisz PA, Lenis AT, et al. Germline variants identified in patients with early-onset renal cell carcinoma referred for germline genetic testing. Eur Urol Oncol. 2021;4:993\u20131000.","journal-title":"Eur Urol Oncol"},{"key":"2006_CR13","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1001\/jamaoncol.2018.1986","volume":"4","author":"MI Carlo","year":"2018","unstructured":"Carlo MI, Mukherjee S, Mandelker D, Vijai J, Kemel Y, Zhang L, et al. Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma. JAMA Oncol. 2018;4:1228\u201335.","journal-title":"JAMA Oncol"},{"key":"2006_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.annpat.2020.02.022","volume":"40","author":"V Verkarre","year":"2020","unstructured":"Verkarre V, Morini A, Denize T, Ferlicot S, Richard S. [Hereditary kidney cancers: The pathologist\u2019s view in 2020]. Ann Pathol. 2020;40:148\u201367.","journal-title":"Ann Pathol"},{"key":"2006_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"2006_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.737547","volume":"11","author":"W Kong","year":"2021","unstructured":"Kong W, Yang T, Wen X, Mu Z, Zhao C, Han S, et al. Germline mutation landscape and associated clinical characteristics in chinese patients with renal cell carcinoma. Front Oncol. 2021;11:737547.","journal-title":"Front Oncol"},{"key":"2006_CR17","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1093\/hmg\/ddac089","volume":"31","author":"B Yngvadottir","year":"2022","unstructured":"Yngvadottir B, Andreou A, Bassaganyas L, Larionov A, Cornish AJ, Chubb D, et al. Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma cases. Hum Mol Genet. 2022;31:3001\u201311.","journal-title":"Hum Mol Genet"},{"key":"2006_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108926","volume":"34","author":"S Abou Alaiwi","year":"2021","unstructured":"Abou Alaiwi S, Nassar AH, Adib E, Groha SM, Akl EW, McGregor BA, et al. Trans-ethnic variation in germline variants of patients with renal cell carcinoma. Cell Rep. 2021;34:108926.","journal-title":"Cell Rep"},{"key":"2006_CR19","doi-asserted-by":"publisher","DOI":"10.1200\/PO.23.00168","volume":"7","author":"CB Nguyen","year":"2023","unstructured":"Nguyen CB, Knaus C, Li J, Accardo ML, Koeppe E, Vaishampayan UN, et al. Pathogenic germline mutational landscape in patients with renal cell carcinoma and associated clinicopathologic features. JCO Precis Oncol. 2023;7:e2300168.","journal-title":"JCO Precis Oncol"},{"key":"2006_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/jmedgenet-2014-102912","volume":"52","author":"PR Benusiglio","year":"2015","unstructured":"Benusiglio PR, Couv\u00e9 S, Gilbert-Dussardier B, Deveaux S, Le Jeune H, Da Costa M, et al. A germline mutation in PBRM1 predisposes to renal cell carcinoma. J Med Genet. 2015;52:426\u201330.","journal-title":"J Med Genet"},{"key":"2006_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2022.104538","volume":"65","author":"M Louise M Binderup","year":"2022","unstructured":"Louise M Binderup M, Smerdel M, Borgwadt L, Beck Nielsen SS, Madsen MG, M\u00f8ller HU, et al. von Hippel-Lindau disease: updated guideline for diagnosis and surveillance. Eur J Med Genet. 2022;65:104538.","journal-title":"Eur J Med Genet"},{"key":"2006_CR22","first-page":"1962","volume":"31","author":"Y Sekine","year":"2022","unstructured":"Sekine Y, Iwasaki Y, Aoi T, Endo M, Hirata M, Kamatani Y, et al. Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls. Hum Mol Genet. 2022;31:1962\u20139.","journal-title":"Hum Mol Genet"},{"key":"2006_CR23","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41436-020-01062-0","volume":"23","author":"M Santos","year":"2021","unstructured":"Santos M, Lanillos J, Rold\u00e1n-Romero JM, Caleiras E, Montero-Conde C, Casc\u00f3n A, et al. Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma. Genet Med. 2021;23:698\u2013704.","journal-title":"Genet Med"},{"key":"2006_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-020-00148-7","volume":"5","author":"RH Kim","year":"2020","unstructured":"Kim RH, Wang X, Evans AJ, Campbell SC, Nguyen JK, Farncombe KM, et al. Early-onset renal cell carcinoma in PTEN harmatoma tumour syndrome. NPJ Genom Med. 2020;5:40.","journal-title":"NPJ Genom Med"},{"key":"2006_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.humpath.2022.07.022","volume":"133","author":"P Kapur","year":"2023","unstructured":"Kapur P, Rajaram S, Brugarolas J. The expanding role of BAP1 in clear cell renal cell carcinoma. Hum Pathol. 2023;133:22\u201331.","journal-title":"Hum Pathol"},{"key":"2006_CR26","doi-asserted-by":"crossref","unstructured":"Lee J, Moon S, Kwon HJ, Lee S, Choe G, Lee KS et al. Evaluation of PD-L1 expression in PBRM1-altered clear cell renal cell carcinoma. Urol Oncol. 2024 [cited 2024 Nov 12]; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1078143924006586.","DOI":"10.1016\/j.urolonc.2024.09.013"},{"key":"2006_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.humpath.2022.12.013","volume":"134","author":"R Mannan","year":"2023","unstructured":"Mannan R, Wang X, Bawa PS, Chugh S, Chinnaiyan AK, Rangaswamy R, et al. Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase-deficient renal cell carcinoma. Hum Pathol. 2023;134:102\u201313.","journal-title":"Hum Pathol"},{"key":"2006_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/modpathol.2014.86","volume":"28","author":"SR Williamson","year":"2015","unstructured":"Williamson SR, Eble JN, Amin MB, Gupta NS, Smith SC, Sholl LM, et al. Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma. Mod Pathol. 2015;28:80\u201394.","journal-title":"Mod Pathol"},{"key":"2006_CR29","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1136\/jmedgenet-2018-105427","volume":"55","author":"DE Benn","year":"2018","unstructured":"Benn DE, Zhu Y, Andrews KA, Wilding M, Duncan EL, Dwight T, et al. Bayesian approach to determining penetrance of pathogenic SDH variants. J Med Genet. 2018;55:729\u201334.","journal-title":"J Med Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-02006-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-02006-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-02006-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:57:00Z","timestamp":1772715420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-02006-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2006"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-02006-5","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the APHP Centre Research Ethics Board (IRB #IORG0010044). All patients provided written informed consent for genetic analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}